Array CGH analysis of pediatric medulloblastomas

Genes Chromosomes and Cancer

Volumn 45, Issue 3, 2006, Pages 290-303

  Rossi, Michael R ^a   Conroy, Jeffrey ^a   McQuaid, Devin ^a   Nowak, Norma J ^a,b   Rutka, James T ^c   Cowell, John K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BRAIN TUMOR; CHILDHOOD CANCER; CHROMOSOME BREAKAGE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOLECULAR CLONING; PRIORITY JOURNAL;

CEREBELLAR NEOPLASMS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN; HUMANS; MEDULLOBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 32544441908     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20292     Document Type: Article

References (56)

1. Albertson DG, Pinkel D. 2003. Genomic micro-arrays in human genetic disease and cancer. Hum Mol Genet 2:145-152.
2. Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE. 2002a. MYC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 126:540-544.
3. Aldosari N, Wiltshire RN, Dutra A, Schrock E, McLendon RE, Friedman HS, Bigner DD, Bigner SH. 2002b. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft. Neurooncol 4:75-85.
4. Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G. 1999. Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer 79:1843-1847.
5. Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, Friedman HS, Bigner DD, Bigner SH. 1995. Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:39-45.
6. Bayani J, Zielenska M, Marrano R Kwan Ng Y, Taylor MD, Jay V, Rutka JT, Squire JA. 2000. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg 93:437-448.
7. Biegel JA. 1999. Cytogenetics and molecular genetics of childhood brain tumors. Neuro-oncol 1:139-151.
8. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD. 1988. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405-411.
9. Cogen PH. 1991. Prognostic significance of molecular genetic markers in childhood brain tumors. Pediatr Neurosurg 17:245-250.
10. Cogen PH, McDonald JD. 1996. Tumor suppressor genes and medulloblastoma. J Neuro-oncol 29:103-111.
11. Cohen N, Betts DR, Tavori U, Toren A, Ram T, Constantini S, Grotzer MA, Amariglio N, Rechavi G, Trakhtenbrot L. 2004. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization. Cancer Genet Cytogenet 149:44-52.
12. Cowell JK, Nowak NJ. 2003. High resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genomic hydridization. Adv Cancer Res 90:91-125.
13. Cowell JK, Matsui S, Wang J, LaDuca J, Conroy J, McQuaid D, Nowak NJ. 2004. Application of comparative genome hybridization using BAC arrays (CGHa) and spectral karyotyping (SKY) to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 151:36-51.
14. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, Burger PC. 2002. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12:36-44.
15. Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, Dang CV, Burger PC. 2004. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol 63:441-449.
16. Ellison D. 2002. Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 28:257-282.
17. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
18. Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L, Gilbertson RJ. 2004. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984-993.
19. Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Jones-Wallace D, Crolla J, Perry R, Lunec J, Pearson A, Ellison D. 2001. Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705-712.
20. Gilhuis HJ, Anderl KL, Boerman RH, Jeuken JM, James CD, Raffel C, Scheithauer BW, Jenkins RB. 2000. Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature. Clin Neurol Neurosurg 102:203-209.
21. Hampe W, Rezgaoui M, Hermans-Borgmeyer I, Schaller HC. 2001. The genes for the human VPS10 domain-containing receptors are large and contain many small exons. Hum Genet 108:529-536.
22. Hui AB, Takano H, Lo KW, Kuo WL, Lam CN, Tong CY, Chang Q, Gray JW, Ng HK. 2005. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Clin Cancer Res 11:4707-4716.
23. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT. 2001. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61:2055-2061.
24. Jung HL, Wang KC, Kim SK, Sung KW, Koo HH, Shin HY, Ahn HS, Shin HJ, Cho BK. 2004. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas. J Neurooncol 67:41-46.
25. Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW. 2004. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 10:5482-5493.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
27. Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voute PA, Baas F, Hermsen MA. 2002. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol 24:205-210.
28. Nicholson JC, Ross FM, Kohler JA, Ellison DW. 1999. Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours. Br J Cancer 80:1322-1331.
29. Nishizaki T, Harada K, Kubota H, Ozaki S, Ito H, Sasaki K. 1999. Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization. Pediatr Neurosurg 31:27-32.
30. Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell JK, Carter R, Goggins MG, Hruban RH, Maitra A. 2005 Genome wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 161:36-50.
31. Nowak NJ, Snijders AM, Conroy JM, Albertson DG. 2005. The BAC resource: tools for array CHG and FISH. Curr Protocols Human Genet 4:1-36.
32. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P. 2004. Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899.
33. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 4:557-572.
34. Ozer E, Sarialioglu F, Cetingoz R, Yuceer N, Cakmakci H, Ozkal S, Olgun N, Uysal K, Corapcioglu F, Canda S. 2004. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study. Pathol Res Pract 200:501-519.
35. Packer RJ. 1990. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28:823-838.
36. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D. Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
37. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR. 2002. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442.
38. Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE. 2004. A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620.
39. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, Look AT. 1997. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 57:4042-4047.
40. Roberts P, Chumas PD, Picton S, Bridges L, Livingstone JH, Sheridan E. 2001. A review of the cytogenetics of 58 pediatric brain tumors. Cancer Genet Cytogenet 131:1-12.
41. Rosenthal JA, Chen H, Slepnev VI, Pellegrini L, Salcini AE, Di Fiore PP, DeCamilli P. 1999. The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module. J Biol Chem 274:33959-33965.
42. Rossi MR, Gaile D, McQuaid D, LaDuca J, Matsui S, Conroy J, Chervinsky D, Eddy R, Chen H-S, Barnett GH, Nowak NJ, Cowell JK. 2005a. Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based comparative genomic hybridization. Genes Chromosomes Cancer 44:85-96.
43. Rossi MR, LaDuca J, Matsui S, Nowak NJ, Hawthorn L, Cowell JK. 2005b. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer 44:392-404.
44. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG. 1999. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86:331-339.
45. Sansal I, Sellers WR. 2004. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954-2963.
46. Saitoh T, Hirai M, Katoh M. 2001. Molecular cloning and characterization of human Frizzled-8 gene on chromosome 10p11.2. Int Oncol 18:991-996.
47. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press.
48. Saylors RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM. 1991. Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51:4721-4723.
49. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL. 1994. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867-12871.
50. Schutz BR, Scheurlen W, Krauss J, du Manoir S, Joos S, Bentz M, Lichter P. 1996. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 16:196-203.
51. Snidjers A, Nowak N, Seagraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle A, Huey B, Kimura K, Law S, Myambo K, Palmer J, Yistra B, Yue J, Gray J, Jain A, Pinkel D, Albertson D. 2001. Assembly of microarrays for genome-wide measurement of DNA copy number by CGH. Nat Genet 29:263-264.
52. Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL, Poon WS, Ng HK. 2004. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg 100:187-193.
53. Vincan E. 2004. Frizzled/WNT signalling: the insidious promoter of tumour growth and progression. Front Biosci 9:1023-1034.
54. Yamada E, Tsujikawa K, Itoh S, Kameda Y, Kohama Y, Yamamoto H. 2000. Molecular cloning and characterization of a novel human STE20-like kinase, hSLK. Biochim Biophys Acta 1495:250-262.
55. Yin XL, Pang JC, Ng HK. 2002. Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma. Oncogene 21:1461-1468.
56. Zakrzewska M, Rieske P, Debiec-Rychter M, Zakrzewski K, Polis L, Fiks T, Liberski PP. 2004. Molecular abnormalities in pediatric embryonal brain tumors-analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22. Clin Neuropathol 23:209-217.